Cargando…
Identifying a Polymorphic ‘Switch’ That Influences miRNAs' Regulation of a Myasthenia Gravis Risk Pathway
The significant roles of genetic variants in myasthenia gravis (MG) pathogenesis have been demonstrated in many studies, and recently it has been revealed that aberrant level/regulation of microRNAs (miRNAs) might contribute to the initiation and progression of MG. However, the dysfunction of miRNA...
Autores principales: | Yang, Lili, Wang, Jianjian, Sun, Xuesong, Cao, Yuze, Ning, Shangwei, Zhang, Huixue, Chen, Lixia, Li, Ronghong, Tian, Qinghua, Wang, Lihua, Wang, Weizhi, Li, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130595/ https://www.ncbi.nlm.nih.gov/pubmed/25118158 http://dx.doi.org/10.1371/journal.pone.0104827 |
Ejemplares similares
-
Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis
por: Cao, Yuze, et al.
Publicado: (2015) -
Corrigendum to “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017) -
Response to: Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017) -
Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis
por: Cao, Yuze, et al.
Publicado: (2017) -
Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis
por: Li, Shuang, et al.
Publicado: (2019)